Physician profile
Sidney Imperial
NPI 1811223530
$2,278.75
in general payments reported to CMS, 2019-2025
14 companies · $242 in 2025
The $242 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $572 · 2020: $79.83 · 2021: $377 · 2022: $266 · 2023: $480 · 2024: $262 · 2025: $242.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $623 · Gift: $360.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $622.97 |
| Gift | $360.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Visionary Optics LLC | $360.00 | 2023 | |
| Johnson & Johnson Vision Care, INC. | $271.41 | 2019-2024 | |
| Alcon Vision LLC | $254.40 | 2019-2024 | |
| Bausch & Lomb Americas INC. | $232.44 | 2022-2023 | Infuse |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $181.40 | 2020-2021 | |
| Coopervision INC. | $151.98 | 2019 | |
| Shire North American Group INC | $126.68 | 2019 | |
| Ocular Therapeutix, INC. | $125.00 | 2021 | |
| Alexion Pharmaceuticals, INC. | $121.86 | 2025 | Ultomiris |
| Carl Zeiss Meditec USA, INC. | $120.75 | 2021-2025 | Clarus |
| Rxsight INC | $105.62 | 2022 | |
| Sun Pharmaceutical Industries INC. | $99.68 | 2025 | |
| Glaukos Corporation | $89.21 | 2024 | Ce-Marked Kxla System |
| Allergan, INC. | $38.32 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sidney Imperial listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.